All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Lymphoma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

Ulrich JägerScientific Advisory Board Member

Professor Ulrich Jäger is a Professor of Hematology at Medizinische Universitsat Wien, Vienna, AT, and Head of the Clinical Department for Hematology and Hemostaseology at the Vienna General Hospital, Vienna, AT. Prof. Jäger obtained his university degree in General Internal Medicine at the University of Vienna, AT, with specialization in hematology/oncology.

His research areas of interest include lymphoproliferative diseases (leukemia and lymphoma), chronic lymphocytic leukemia, non-Hodgkin lymphoma, acute lymphocytic leukemia, antibody therapies, and autoimmune hemolytic anemias.

Positions of responsibility/awards:

  • President of the European Hematology Association (EHA) between 2011−2013
  • Member of the Austrian Society of Hematology and Medical Oncology and the Austrian Society of Internal Medicine
  • Member of the American Society of Hematology
  • Member of the European LeukemiaNet, EHA, and the German CLL study group
  • Winner of the Wilhelm Türk Prize of the Austrian Society for Hematology and Oncology in 1993, 1998 (together with Prof. Dr K. Laczika), 2002 (together with Dr M. N. Welzel), and 2003 (together with Dr R. Marculescu)
  • Winner of the Prize of the "Erste Österreichische Sparkasse" (together with Dr R. Marculescu) in 2002
  • Winner of the Aventis Prize, 2003, 2004
  • Winner of "Großer Zentraluropäischer Preis" of the Vienna City Fund for innovative interdisciplinary cancer research, 2012
  • Reviewer in top medical journals: Section Editor of the Annals of Hematology and Editor-in-Chief of the Vienna Clinical Weekly
|||